Surgical treatment of fractures close to joints, especially in osteoporotic patients, is often associated with problems to obtain adequate strength of the bone-implant construct as well as sufficient purchase for screws in the weak bone. One way to address this increasing problem is through the development of new metal implants specifically designed for fixation of fractures in osteopenic bone. An alternative strategy is to develop methods for augmentation of the weak bone that surrounds the metal implant. In most instances augmentation is achieved by using injectable cement to reinforce the bone. Conventional PMMA provides good strength but due to several drawbacks it has never gained general acceptance for fracture augmentation. More recently several injectable cements based on calcium-phosphate, calcium-sulphate or bioglass has been developed for augmentation of fractures in the extremities as well as for vertebral compressive fractures in the spine. On the basis of biomechanical studies and the clinical experience so far, cement augmentation will enable faster rehabilitation, as the strength of the cement makes it possible to allow full weight-bearing earlier than conventional metal implants alone. More clinical studies are needed in order to refine the surgical technique, develop cement types aimed for fracture treatment and define the most appropriate indications and limitations of augmentation for fracture repair.
INTRODUCTION
Whenever surgical treatment is indicated fractures that involve the shaft of long bones can usually be managed with traditional metal due to the mechanical strength in the cortical bone. However, in patients with osteopenic bone there might be a problem to achieve an adequate strength of the bone-implant construct as well as enough purchase for screws in the weak bone. The classic way to address this increasing problem has been by the development of new metal implants aimed for fixation of fractures in osteopenic bone. Such systems usually include new types of screws to enhance the holding power. A recent development is the introduction of so called angle-stable screw plate systems where each screw can be locked to the plate and thereby less dependent on the bone quality for holding power. An alternate strategy is to develop methods for augmentation of the weak bone that surrounds the metal implant. In most instances this is achieved by some kind of injectable cement to reinforce the bone around the metal.
Internal fixation of metaphyseal fractures might be difficult even in patients with a normal bone quality, because of the low strength in the cancellous bone that makes up the major part of the metaphysis (20) . In addition, the fragment closest to the joint is often short, and frequently there is also an intra-articular component. Crushing of subchondral cancellous bone by the depressed articular fragments at the time of injury often complicates stabilisation. Most commonly, the subchondral void is filled with autologous bone graft. However, this procedure carries serious drawbacks, such as donor site morbidity and the limited immediate mechanical stability afforded by cancellous autograft. Despite the potential technical difficulties, internal fixation of metaphyseal fractures is usually recommended because good fracture stability is a prerequisite for early return to adequate joint function. By using injectable cement for augmentation it might be possible to improve the mechanical strength when fixing metaphyseal fractures.
Another indication for augmentation is seen in the increasing number of patients with osteoporosis who suffer from vertebral compressive fractures following low energy trauma. The traditional treatment involves analgesia, bed rest and mobilisation. Over the last years an alternative type of treatment has been popularised that involves percutaneous structural reinforcement, i.e. augmentation, of the vertebral body to reduce pain and facilitate mobilisation. In the original technique a transpedicular approach was used to inject cement into the crushed vertebra. More recently another technique has been described where a cavity within the injured vertebra is created before the cement injection.
The purpose of this article is to review the possible use of augmentation as a technique in the treatment of fractures in the extremities as well as in the spine.
MATERIALS FOR AUGMENTATION PMMA (POLYMETHYLMETHACRYLATE)
Injectable materials that harden in situ such as polymethylmetacrylate (PMMA) can be used to improve screw purchase in osteoporotic bone and also as structural support to improve the bone-implant construct stability of metaphyseal fractures in osteoporotic patients (3, 35, 41) . Even though the use of PMMA has been established for decades as the gold standard in arthroplasty, it has not gained wide acceptance when used for fracture treatment in the extremities. This is probably because of its exothermic reaction during curing, the inability of the cement to be remodelled, the risk of inhibiting fracture healing if the PMMA is interposed between fracture surfaces, and difficulty in removing the PMMA if revision surgery becomes necessary.
In the spine the use of PMMA has on the other hand become popular over the last decade for filling of compressed painful vertebrae in osteoporotic patients, when performing so called percutaneous vertebroplasty (PVP) or kyphoplasty (KVP) (2, 4, 9, 10, 20, 27, 30). For this indication it has even been discussed that the potential tissue damage caused by the exothermic reaction might contribute to the pain relief due to denervation in the vertebra.
CALCIUM-PHOSPHATE CEMENT
The solution for many of the problems encountered with PMMA when used for augmentation of fractures that involves crushed cancellous bone, or osteoporotic bone, may lie in other cement types such as calcium-phosphate. This type of cement is delivered as two components, a powder and a fluid. The powder is usually a mix of monocalcium phosphate, monohydrate, tricalcium phosphate, and calcium carbonate while the fluid is a sodium phosphate solution. In the operating room the powder and fluid are mixed into an injectable paste, either manually or with the use of a mixing machine. After injection, the paste hardens within a few minutes to form a carbonated calcium-phosphate apatite very similar to the mineral phase of bone (8, 16). As it is injected, the cement interdigitates with adjacent bone, forming a solid structure that is more mechanically stable than cancellous bone graft. Fully cured calciumphosphate has a compressive strength between that of cancellous and cortical bone, but tensile and shear strength much lower than cancellous bone.
The and BoneSource™ but which appears to be absorbed more rapidly in vivo (38) .
Animal studies have shown that calcium-phosphate is osteoconductive and undergoes gradual remodelling over time (12) . Over time there seems to be osteoclastic resorption of the cement, vascular penetration, and bone formation in a pattern that suggests remodelling similar to that of normal bone. There have been some reports of the histology of calcium-phosphate cement in humans (17, 25, 42) .
BIOGLASS
Another group of injectable cements are composed of combinations of bioactive glass ceramic powders with resins. Several formulations of cement in which bioactive glass powders are combined with a bisphenol-a-glycidyl methacrylate (Bis-GMA)-based resin have been developed (15, 22, 36, 45) . Preclinical studies have tested these cements in the spine. Other formulations of bioactive cements composed of Bis-GMA-based resins mixed with combeite glassceramic fillers (e.g. Cortoss ® , Orthovita inc, Malvern, USA) have been developed and used for fractures in the extremities and the spine (37). In a study on ankle fractures in osteopenic patient's augmentation of metal screws with Bis-GMA was an effective method to reduce the risk for screw loosening (1).
SPECIFIC INDICATIONS AUGMENTATION OF METAPHYSEAL FRACTURES TROCHANTERIC HIP FRACTURES
Surgical treatment is the preferred option in almost all hip fracture patients. The treatment aims to produce fracture stability that will allow unrestricted weight-bearing directly after surgery. This is because most patients who suffer a hip fracture are elderly, with limited strength in their upper extremities that makes it difficult for them to reduce the weight carried by the injured hip. Unfortunately, the bone is often weakened by osteoporosis, which hampers the ability to achieve stability. Trochanteric fractures, which are almost as common as femoral neck fractures, only rarely present any healing difficulties. The main concerns are instead related to mechanical problems when attempting to achieve stability (7, 8, 26, 50) . Two-part fractures seldom present any problems, but multi-fragmentary so called unstable fractures, especially those without posteromedial support, are often technical challenges. In experimental unstable trochanteric fractures PMMA has been shown to enhance the strength when used for augmentation. In clinical studies this finding has been verified with good results in osteoporotic fractures (3, 35, 41). Even given the favourable outcome in clinical series, augmentation with PMMA in trochanteric fracture surgery has never gained wide clinical acceptance. In a recent study injection of Bis-GMA (Cortoss, Orthovita Inc) around lag screws inserted for fixation of trochanteric fractures provided a significant enhancement of the torque resistance and reduced risk for cutting out of the lag screw in osteopenic patients.
In two biomechanical studies, trochanteric fractures with a detached minor trochanter were created and fixed with a sliding screw device alone or in combination with calcium-phosphate for augmentation to fill the posteromedial defect (11, 49) . Cyclic loading revealed that the specimens augmented with cement had significantly higher stiffness, stability, and strength, and less shortening at the fracture site. In addition, the strain on the medial bone surface in the augmented specimens was closer to normal than the strain in the specimens fixed with the metal device alone.
In a prospective, randomised clinical study, patients with a trochanteric fracture that included a detached posteromedial fragment were treated with surgical fixation using a conventional sliding screw system alone or in combination with calcium-phosphate ( Fig. 1) (32) . The purpose of augmentation was to restore a mechanically competent posteromedial arch that enabled a more efficient transfer of load between fracture ends while reducing the risk for secondary fracture displacement and cutting out of the lag screw. The fractures augmented with cement were significantly more stable, with reduced overall movement, less distal displacement, and less varus angulation when compared with fractures fixed with the metal device alone. Quality of life variables were also more favourable in the augmented group during the course of healing.
FEMORAL NECK FRACTURES
In undisplaced femoral neck fractures internal fixation is usually preferred, as it will provide a good outcome in most patients, while in displaced fractures the high complication rate after internal fixation has favoured prosthetic replacement, especially in elderly patients (29). Even though deficient blood flow is the primary cause for complications in displaced femoral neck fractures, there are reports indi- cating that good primary stability can improve outcomes after internal fixation (39). Stankewich and coworkers (44) studied the use of calcium-phosphate cement to augment comminute femoral neck fractures fixed with cannulated screws. Under cyclic loading, the augmented specimens were significantly stiffer and they failed at higher loads. In a prospective and randomised clinical study, patients with displaced femoral neck fractures were allocated to treatment with closed reduction and internal fixation with two cannulated screws either alone or in combination with calcium-phosphate for augmentation (34). The cement was used to augment the bone around the screw threads to enhance the holding characteristics in the femoral head and to fill the fracture void. The patients were examined with radiostereometric analysis (RSA), a radiological technique that allows 3-dimensional description of movement with a high accuracy (43) , conventional radiographs as well as clinical variables. The RSA study showed significantly better stability in the cement-augmented fractures during the early rehabilitation period, although there were no significant differences between the groups at 6, 12 and 24 months (34). There was no significant difference in the reoperation rates although a tendency towards more frequent early reoperations due to secondary displacement in the control group and more frequent late reoperations due to nonunion or avascular necrosis in the augmented group.
TIBIAL PLATEAU FRACTURES
Fractures of the tibial plateau often involve depression of articular fragments and instability that makes surgery necessary to restore intraarticular anatomy and joint stability. Elevating the depressed articular fragments often reveals a metaphyseal void outlined by crushed cancellous bone. This void is commonly filled with autologous bone graft or with preformed blocks or granules composed of sintered, highly crystalline hydroxyapatite (5). Although autograft has desirable biological properties, it does not provide enough mechanical stability to allow full weightbearing until the fracture has healed. Calcium-phosphate and other injectable bioactive cements such as calcium-sulphate can completely fill the defect to produce immediate stability, and they also develop enough compressive strength to facilitate earlier active joint motion and shorter time to full weight-bearing than bone graft procedures (Fig. 2) (21, 26, 28, 38, 48) . In a series of 41 patients with an isolated tibial plateau fracture, Keating et al (21) allowed free weight bearing 6 weeks after surgery when using Norian SRS ® to supplement internal fixation in tibial plateau fractures. Despite the early weight-bearing, they reported substantial loss of reduction in only one patient, an elderly man with poor compliance. Two randomised studies comparing injectable calcium-phosphate cement versus bone graft for filling of the subchondral void in tibial plateau fractures revealed that the patients in the augmented group had less pain and were able to return to full weight bearing earlier. Despite more aggressive loading during the course of healing the elevated articular fragment subsided less in the group augmented with cement compared with the group treated with conventional bone graft (26, 38).
CALCANEAL FRACTURES
The proper treatment of intraarticular calcaneal fractures is still controversial. To some extent, the reluctance to perform surgery on these fractures seems to be attributable to the technical difficulties of trying to restore the anatomy of the subtalar joints. Not only is it often a substantial technical challenge to reduce the multiple bone fragments, but in addition it is often difficult to maintain joint congruency during the healing period.
The limited stability of the fracture fragments achieved with metal fixation is to a large extent due to the cancellous bone defect that is regularly present under the subtalar joints. This defect seems to be attributable to the crushed cancellous bone, similar to that seen in tibial plateau fractures, made worse by the reduced cancellous bone density commonly found in this part of the calcaneus. Whether or not bone graft is being used to fill this defect, restricted weight-bearing is usually recommended for 8 to 12 weeks.
The rationale for using injectable, bioactive cement in calcaneal fractures is to fill the void under the subtalar joints, thereby providing an augmented construct. This should allow earlier return to full weightbearing and faster restoration of ankle and foot function without increasing the risk for secondary displacement of the fractured joint surfaces. In a biomechanical study, Thorardson and co-workers compared intraarticular calcaneal fractures fixed with standard internal fixation with those in which the osseous defect was filled with either bone graft or calcium-phosphate (46) . In the specimens treated with the combination of hardware and cement, cyclic loading produced significantly less deformation. In a prospective clinical series, 36 calcaneal fractures with joint depression were treated with a combination of internal fixation and calcium-phosphate cement (32). Through the series, progressively shorter times to full weight-bearing were prescribed. The last patients were allowed full weight-bearing 3 weeks after surgery and showed no radiological evidence of loss of reduction. In another clinical series fifteen patients had open reduction and internal fixation with conventional metal combined with calciumphosphate for augmentation followed by weightbearing at three weeks after surgery without any loss of reduction (47) .
DISTAL RADIAL FRACTURES
Fractures of the distal radius are very common injuries. Treatment with closed reduction and plaster usually works well, especially for patients who have little initial displacement, limited comminution, and good bone quality. On the other hand, fractures with severe comminution, bone loss at the fracture site, or involving osteoporotic bone may be difficult to stabilize with plaster alone, and the risk for secondary displacement and malunion is high. The use of bioactive cement may make it possible to fill the metaphyseal defect, improve fracture stability, and reduce immobilization time (Fig. 3) . In a biomechanical study, Yetkinler and co-workers (53) tested the stability of intraarticular fractures of the distal radius stabilized with either Kirschner wires or calciumphosphate cement. The fractures augmented with cement were significantly more stable and had a significantly higher strength when subjected to cyclic loading as well as when loaded to failure.
The use of calcium phosphate cement to treat distal radius fractures has been studied for fresh fractures as well as for fractures that had become displaced after primary treatment with closed reduction and plaster (6, 19, 23, 40) . In fresh fractures, percutaneous injection of the cement worked well in providing adequate filling of the fracture void. In a randomised study by Sanchez-Sotelo et al (42) augmentation using calcium-phosphate cement was compared versus treatment with cast. It was concluded that augmentation provided a better clinical and radiological result than conventional treatment. In another randomised multicenter study of patients with fresh distal radius fractures, cement augmentation combined with a short period of plaster immobilisation was compared with conventional external fixation (6). The group treated with cement augmentation had a significantly faster gain in grip strength and range of movement for the first eight weeks after the injury, although there were no significant differences at final follow-up at one year.
In patients who need a secondary procedure after redislocation in plaster, an open cementing technique that includes evacuating the organised haematoma before injecting the cement has been recommended (23). In a randomised study on redisplaced fractures of the distal radius, cement augmentation combined with 2 weeks of plaster immobilisation was compared with external fixation. The authors concluded that the patients in the augmented group regained a good grip strength and functional recovery faster than patients treated with external fixation. The faster recovery was considered to depend mainly on the more rapid rehabilitation program that could be applied in the augmented group.
AUGMENTATION OF SPINAL COMPRESSIVE FRACTURES
In the 1980's a technique called "percutaneous vertebroplasty (PVP)" was developed for the treatment of vertebral haemangioma. The method consists of a percutaneous injection of bone cement, i.e. polymethylmethacrylate (PMMA), under fluoroscopy guidance. Due to its positive effect on the back pain the same method was later assessed for treatment of vertebral compression fractures in osteoporotic patients. This type of spinal injury is relatively common, and it is often responsible for persistent and severe pain. The injection of polymethylmethacrylate cement into the vertebral body has shown promise for rapid pain relief and possibly structural strengthening of osteoporotic vertebral bodies (Fig. 4) (2, 9, 10) . The drawbacks with the procedure include the risk for leakage of the injected cement into the adjacent structures, especially epidural, foraminal or venous leakage and an increased risk for new vertebral fractures adjacent to the treated vertebra (13, 18) . So far, percutaneous vertebroplasty has only been assessed in clinical series. There are no publications using a randomised controlled design to compare the technique with conventional conservative treatment. A controlled evaluation of the long-term results is needed. Percutaneous vertebroplasty (PVP) does not attempt to restore vertebral body height and thus correct the kyphotic deformity of vertebral collapse. In recent years a procedure called kyphoplasty (KVP) has been developed to address this issue as well as reduce the risk for leakage of cement outside the vertebra (20, 30 ). An inflatable balloon is inserted into the centre of the fractured vertebra using the trans-or extrapedicular approach. The balloon is then inflated to impact cancellous bone circumferentially around the balloon and thus creating a void while on the same time reducing the deformity. The central void is then filled with cement. So far only nonrandomised reports have been published using this technique. It still has to be shown to what extent any significant restoration of vertebra height can be gained using KVP as well as whether the preformed void in the vertebra will reduce the risk for cement leakage.
The result of vertebroplasty in terms of relief of debilitating pain might be dramatic according to sev- eral authors, with significant improvement in 80 to 90% of patients. However, the indications for vertebroplasty or kyphoplasty in the treatment of osteoporotic vertebral fractures are still evolving.
SCREW AUGMENTATION
Fixation of osteoporotic fractures with screws alone is not common due to the risk of inadequate purchase in the bone and cutting out prior to healing. However, in most fixation systems, intramedullary or extramedullary, screws are still important keystones. By changing design of the threads, changing screw dimensions, as well as other features, screws with improved holding characteristics have been developed for use in osteoporotic fractures. Still, it seems as the most reliable pathway to successful use of screws in osteoporotic bone is through augmentation of the bone that surrounds the implants. Cannulated screws with side holes are therefore being used that allow injection of bone cement through the screw into the cancellous bone around the threads. Following hardening of the cement the holding power of such a screw will be substantially improved compared with screws without bone cement around the threads. If such screws are not available cement can be injected into the drill hole and the screw inserted before hardening. Instead of screws with threads, expandable anchors have been tested in biomechanical studies with good results.
ADVANTAGES AND LIMITATIONS OF CEMENT AUGMENTATION FOR FRACTURES
The preclinical and biomechanical studies of augmentation are promising, but clinical experience thus far is based on rather few studies in a few clinical indications. Although the gains in stiffness and strength are clear, additional work should be done to ensure that the cement itself does not have any detrimental effect on the healing process.
A major drawback with present calcium-phosphate and calcium-sulphate cement is the low shear and tension strength while a major advantage is the favourable biological response. The clinical studies using calcium-phosphate cement on tibial plateau fractures suggest that cement augmentation is beneficial in this indication, probably because the cement is subjected to relatively uniform compressive loading.
The use of bioactive cements will not replace the use of conventional metal implants but will probably influence the design of metal devices and the way in which they are used. Until cements with adequate shear strength are available, most complex fractures that can be repaired with cement will also require metal supports. Consideration also should be given to new cement formulations that can carry antibiotics or osteoinductive proteins for use in augmentation of fractures or other skeletal defects. 
